DE50103551D1 - Neue tiotropium-haltige inhalationspulver - Google Patents

Neue tiotropium-haltige inhalationspulver

Info

Publication number: DE50103551D1
Authority: DE; Germany
Prior art keywords: inhalation powder; containing inhalation; new tiotropium; tiotropium; new
Prior art date: 2000-10-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE50103551T

Other languages

English (en)

Other versions

DE50103551C5 (de

Inventor

Karoline Bechtold-Peters

Michael Walz

Georg Boeck

Rolf Doerr

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2001-09-28

Publication date

2004-10-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE50103551(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-28 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2001-09-28 Priority to DE50103551.6T priority Critical patent/DE50103551C5/de

2004-10-14 Application granted granted Critical

2004-10-14 Publication of DE50103551D1 publication Critical patent/DE50103551D1/de

2014-08-21 Publication of DE50103551C5 publication Critical patent/DE50103551C5/de

2021-09-29 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DE50103551.6T 2000-10-12 2001-09-28 Neue tiotropium-haltige inhalationspulver Expired - Lifetime DE50103551C5 (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DE50103551.6T DE50103551C5 (de)	2000-10-12	2001-09-28	Neue tiotropium-haltige inhalationspulver

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE10050635		2000-10-12
DE10050635		2000-10-12
PCT/EP2001/011227 WO2002030389A1 (de)	2000-10-12	2001-09-28	Neue tiotropium-haltige inhalationspulver
DE50103551.6T DE50103551C5 (de)	2000-10-12	2001-09-28	Neue tiotropium-haltige inhalationspulver

Publications (2)

Publication Number	Publication Date
DE50103551D1 true DE50103551D1 (de)	2004-10-14
DE50103551C5 DE50103551C5 (de)	2014-08-21

Family

ID=7659578

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE50103551.6T Expired - Lifetime DE50103551C5 (de)	2000-10-12	2001-09-28	Neue tiotropium-haltige inhalationspulver

Country Status (49)

Country	Link
US (4)	US7070800B2 (de)
EP (2)	EP1430887A1 (de)
JP (1)	JP3870159B2 (de)
KR (1)	KR100488644B1 (de)
CN (1)	CN1210017C (de)
AP (1)	AP1712A (de)
AR (1)	AR031819A1 (de)
AT (1)	ATE275391T1 (de)
AU (1)	AU757008B2 (de)
BG (1)	BG65753B1 (de)
BR (1)	BR0107304A (de)
CA (1)	CA2395653C (de)
CR (1)	CR6937A (de)
CU (1)	CU23284B7 (de)
CZ (1)	CZ301465B6 (de)
DE (1)	DE50103551C5 (de)
DK (1)	DK1292281T3 (de)
DZ (1)	DZ3477A1 (de)
EA (1)	EA004034B1 (de)
EC (2)	ECSP024268A (de)
EE (1)	EE04414B1 (de)
EG (1)	EG24139A (de)
ES (1)	ES2227268T3 (de)
GE (1)	GEP20063865B (de)
HK (1)	HK1051812A1 (de)
HR (1)	HRP20020437B1 (de)
HU (1)	HU226982B1 (de)
IL (2)	IL149984A0 (de)
IS (1)	IS2360B (de)
MA (1)	MA25843A1 (de)
ME (2)	ME00245B (de)
MX (1)	MXPA02005666A (de)
MY (1)	MY123544A (de)
NO (1)	NO331956B1 (de)
NZ (1)	NZ519406A (de)
OA (1)	OA12522A (de)
PE (1)	PE20020577A1 (de)
PL (1)	PL200063B1 (de)
PT (1)	PT1292281E (de)
RS (1)	RS50197B (de)
SA (1)	SA01220460B1 (de)
SI (1)	SI1292281T1 (de)
SK (1)	SK285389B6 (de)
TR (1)	TR200402367T4 (de)
TW (1)	TWI285553B (de)
UA (1)	UA72014C2 (de)
UY (1)	UY26959A1 (de)
WO (1)	WO2002030389A1 (de)
ZA (1)	ZA200204378B (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100488644B1 (ko)	2000-10-12	2005-05-11	베링거 잉겔하임 파르마 게엠베하 운트 코 카게	티오트로퓸을 함유하는 신규 흡입용 산제
ES2474199T3 (es)	2000-11-30	2014-07-08	Vectura Limited	Composiciones farmacéuticas para inhalaci�n
WO2002043700A2 (en)	2000-11-30	2002-06-06	Vectura Limited	Particles for use in a pharmaceutical composition
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US20030008001A1 (en) *	2001-06-13	2003-01-09	Boehringer Ingelheim Pharma Kg	Process for cleaning hard gelatine capsules
DE10128779A1 (de) *	2001-06-13	2003-01-02	Boehringer Ingelheim Pharma	Verfahren zur Reinigung von Hartgelatinekapseln
DE10141376A1 (de) *	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) *	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7309707B2 (en) *	2002-03-20	2007-12-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) *	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
RU2004132222A (ru) *	2002-04-04	2005-10-10	Берингер Ингельхайм Фарма Гмбх Унд Ко.Кг (De)	Порошковые композиции, пригодные для ингаляции
US20030235538A1 (en) *	2002-04-09	2003-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Method for the administration of an anticholinergic by inhalation
CA2487399A1 (en) *	2002-06-12	2004-02-19	Epigenesis Pharmaceuticals, Inc.	Combination of anti-muscarinic agents and non-glucocorticoid steroids
MXPA05001903A (es) *	2002-08-21	2005-04-28	Norton Healthcare Ltd	Composicion para inhalacion.
JP2006516531A (ja) *	2002-08-21	2006-07-06	ノートン　ヘルスケアー　リミテッド	吸入組成物
GB0219513D0 (en)	2002-08-21	2002-10-02	Norton Healthcare Ltd	Inhalation compositions including coarse carrier
GB0219511D0 (en) *	2002-08-21	2002-10-02	Norton Healthcare Ltd	Method of preparing dry powder inhalation compositions
US7763280B2 (en)	2002-11-28	2010-07-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) *	2002-11-28	2004-06-09	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US20050058606A1 (en) *	2002-12-16	2005-03-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing HFC solution formulations
US20040152720A1 (en) *	2002-12-20	2004-08-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en)	2003-05-13	2004-11-18	Deem Mark E.	Apparatus for treating asthma using neurotoxin
WO2004112702A2 (en) *	2003-06-13	2004-12-29	Advanced Inhalation Research, Inc.	Low dose pharmaceutical powders for inhalation
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050038004A1 (en) *	2003-07-31	2005-02-17	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
SG137859A1 (en)	2003-11-03	2007-12-28	Boehringer Ingelheim Int	Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
EP2083007B1 (de)	2003-11-03	2013-04-24	Boehringer Ingelheim International Gmbh	Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
SE0303570L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Fukt-känslig medicinsk produkt
AU2004294889B2 (en) *	2003-12-03	2010-08-26	Boehringer Ingelheim International Gmbh	Medical product containing tiotropium
SE0303270L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Metod för administration av tiotropium
EP1691783B1 (de) *	2003-12-03	2009-11-25	Boehringer Ingelheim International GmbH	Vordosierter trockenpulverinhalator für feuchtigkeitsempfindliche medikamente
SE0303269L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Medicinsk produkt
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
JP5156397B2 (ja)	2005-02-10	2013-03-06	グラクソグループリミテッド	予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤
EP2085396A3 (de) *	2005-05-02	2009-11-25	Boehringer Ingelheim International Gmbh	Neue kristalline Formen von Tiotropiumbromid
NZ564697A (en) *	2005-06-15	2010-04-30	Boehringer Ingelheim Int	Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
TWI274641B (en) *	2005-08-30	2007-03-01	Rexon Ind Corp Ltd	Cutting machine
EP1869035B2 (de) *	2005-12-19	2015-08-12	Sicor, Inc.	Neue crystalline tiotropiumbromid-form und verfahren zu deren herstellung
RU2453547C2 (ru) *	2005-12-19	2012-06-20	Сикор Инк.	Новые формы тиотропия бромида и способы их получения
WO2007075838A2 (en) *	2005-12-19	2007-07-05	Sicor Inc.	Pure and stable tiotropium bromide
US9108962B2 (en)	2005-12-19	2015-08-18	Sicor, Inc.	Forms of tiotropium bromide and processes for preparation thereof
US20070167480A1 (en) *	2005-12-19	2007-07-19	Sicor Inc.	Pure and stable tiotropium bromide
US20080051582A1 (en) *	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
GB0716026D0 (en)	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
EP2183262A1 (de)	2007-07-27	2010-05-12	Cargill, Incorporated	Mikronisierung von polyolen
US8483831B1 (en)	2008-02-15	2013-07-09	Holaira, Inc.	System and method for bronchial dilation
EP2529686B1 (de)	2008-05-09	2015-10-14	Holaira, Inc.	System zur Behandlung eines Bronchialbaumes
EP2172190A1 (de)	2008-10-02	2010-04-07	Laboratorios Liconsa, S.A.	Inhalierbare Partikel mit Tiotropium
EP2409977A4 (de)	2009-03-17	2012-09-26	Daiichi Sankyo Co Ltd	Amidderivat
US9649153B2 (en)	2009-10-27	2017-05-16	Holaira, Inc.	Delivery devices with coolable energy emitting assemblies
US8911439B2 (en)	2009-11-11	2014-12-16	Holaira, Inc.	Non-invasive and minimally invasive denervation methods and systems for performing the same
CA2780608C (en)	2009-11-11	2019-02-26	Innovative Pulmonary Solutions, Inc.	Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8834931B2 (en)	2009-12-25	2014-09-16	Mahmut Bilgic	Dry powder formulation containing tiotropium for inhalation
WO2011152804A2 (en) *	2010-06-03	2011-12-08	Mahmut Bilgic	Process for dry powder formulations
TR201007251A2 (tr) *	2010-09-01	2012-03-21	Bi̇lgi̇ç Mahmut	Kalsiyum kanal blokörü formülasyonu.
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US20150165038A1 (en) *	2012-02-10	2015-06-18	Arven llac Sanayi Ve Ticaret A.S.	Compositions comprising muscarinic receptor antagonist and sorbitol
JP6335798B2 (ja)	2012-02-28	2018-05-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規噴射剤含有チオトロピウム製剤
RU2522213C2 (ru) *	2012-06-07	2014-07-10	Шолекс Девелопмент Гмбх,	Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащих в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
US20150165037A1 (en) *	2012-07-05	2015-06-18	Arven llac Sanayi Ve Ticaret A.S.	Inhalation compositions comprising corticosteroid and sorbitol
US20150150802A1 (en)	2012-07-05	2015-06-04	Arven Ilac Sanayi Ve Ticaret Anonim Sirketi	Dry powder inhaler compositions comprising long acting muscarinic antagonists
US20150174064A1 (en) *	2012-07-05	2015-06-25	Arven IIac Sanayi Ve Ticaret A.S.	Compositions comprising muscarinic receptor antagonist and glucose anhydrous
US10105316B2 (en) *	2012-07-05	2018-10-23	Arven llac Sanayi Ve Ticaret A.S.	Inhalation compositions comprising muscarinic receptor antagonist
US10111957B2 (en) *	2012-07-05	2018-10-30	Arven Ilac Snayi ve Ticaret A.S.	Inhalation compositions comprising glucose anhydrous
US20150224197A1 (en) *	2012-07-05	2015-08-13	Arven Ilac Sanayi Ve Ticaret A.S.	Inhalation compositions
EP2705838A1 (de) *	2012-09-06	2014-03-12	Xspray Microparticles Ab	Tiotropium-Zubereitungen
US9398933B2 (en)	2012-12-27	2016-07-26	Holaira, Inc.	Methods for improving drug efficacy including a combination of drug administration and nerve modulation
WO2015065222A1 (ru) *	2013-10-28	2015-05-07	Шолекс Девелопмент Гмбх	Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
EP2913332A1 (de)	2014-02-27	2015-09-02	Euticals S.P.A.	Kristalline Form von Tiotropiumbromid mit Lactose
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
JP2019500916A (ja)	2015-10-23	2019-01-17	アーヴェンイラチュサナイヴェティヂャレットエー．エス．ＡｒｖｅｎＩｌａｃＳａｎａｙｉＶｅＴｉｃａｒｅｔＡ．Ｓ．	臭化チオトロピウムの吸入製剤のためのブリスター
KR101728116B1 (ko) *	2015-11-03	2017-04-18	한미약품 주식회사	티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
RU2762084C2 (ru)	2015-12-24	2021-12-15	Филип Моррис Продактс С.А.	Ароматизированный никотиновый порошок
EA201992234A1 (ru)	2017-03-23	2020-02-05	Сингапур Хелт Сервисиз Пте Лтд	Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
EP4108230A1 (de)	2021-06-24	2022-12-28	Laboratoires SMB	Neue trockenpulverzusammensetzung von tiotropium zur inhalation
GR1010358B (el) *	2021-09-14	2022-12-16	Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια,	Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1242211A (en)	1967-08-08	1971-08-11	Fisons Pharmaceuticals Ltd	Pharmaceutical composition
US3860618A (en)	1967-08-08	1975-01-14	Philip Saxton Hartley	Chromone
US3957965A (en)	1967-08-08	1976-05-18	Fisons Limited	Sodium chromoglycate inhalation medicament
DE2540633A1 (de)	1975-09-12	1977-04-28	Boehringer Sohn Ingelheim	Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de)	1982-03-26	1983-09-29	Boehringer Ingelheim KG, 6507 Ingelheim	Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de)	1982-04-26	1983-11-03	Boehringer Ingelheim KG, 6507 Ingelheim	Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
JPS60172442A (ja)	1984-02-20	1985-09-05	Fanuc Ltd	ならい加工およびνｃ加工による機械加工装置
US5610163A (en)	1989-09-16	1997-03-11	Boehringer Ingelheim Gmbh	Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de)	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4108393A1 (de)	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
US5498422A (en)	1991-04-08	1996-03-12	Nippon Shinyaku Company Limited	Sustained release capsule
DE4140689B4 (de)	1991-12-10	2007-11-22	Boehringer Ingelheim Kg	Inhalationspulver und Verfahren zu ihrer Herstellung
US5770738A (en)	1992-03-05	1998-06-23	Boehringer Ingelheim Kg	Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
US5819730A (en)	1993-06-09	1998-10-13	Glaxo Wellcome Australia Ltd.	Device for administering pharmaceutical substances
ES2308955T5 (es)	1993-09-28	2012-04-03	R.P. Scherer Gmbh	Fabricación de cápsulas de gelatina blanda
GB9322014D0 (en)	1993-10-26	1993-12-15	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) *	1994-03-15	1994-04-27	Glaxo Group Ltd	Pharmaceutical composition
DE4425255A1 (de)	1994-07-16	1996-01-18	Asta Medica Ag	Formulierung zur inhalativen Applikation
DE19515625C2 (de)	1995-04-28	1998-02-19	Boehringer Ingelheim Kg	Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
FR2757173A1 (fr)	1996-12-17	1998-06-19	Warner Lambert Co	Compositions polymeres d'origine non-animale pour la formation de films
US6228394B1 (en) *	1997-10-14	2001-05-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Supercritical fluid extraction of mould lubricant from hard shell capsules
US6235725B1 (en) *	1998-10-30	2001-05-22	Baker Norton Pharmaceuticals, Inc.	Methods and compositions for the prevention of tolerance to medications
DK1283036T3 (da)	1998-11-13	2008-03-25	Jagotec Ag	Törpulver til inhalation
GB9902689D0 (en)	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
US20040002548A1 (en)	1999-05-12	2004-01-01	Boehringer Ingelheim Pharma Kg	Medicament compositions containing anticholinergically-effective compounds and betamimetics
JP3931486B2 (ja)	1999-06-24	2007-06-13	住友化学株式会社	ポジ型レジスト組成物
UA75375C2 (en)	2000-10-12	2006-04-17	Boehringer Ingelheim Pharma	Method for producing powdery preparations for inhaling
US6908928B2 (en) *	2000-10-12	2005-06-21	Bi Pharma Kg.	Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
KR100488644B1 (ko) *	2000-10-12	2005-05-11	베링거 잉겔하임 파르마 게엠베하 운트 코 카게	티오트로퓸을 함유하는 신규 흡입용 산제
DE10064816A1 (de)	2000-12-22	2002-06-27	Boehringer Ingelheim Pharma	Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en)	2001-01-31	2003-01-14	Boehringer Ingelheim Pharma Ag	Process for preparing a scopine ester intermediate
DE10126924A1 (de)	2001-06-01	2002-12-05	Boehringer Ingelheim Pharma	Inhalationskapseln
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US6482429B1 (en)	2001-06-20	2002-11-19	Boehringer Ingelheim Pharmaceuticals, Inc.	Stable powder inhalation dosage formulation
DE10141376A1 (de) *	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de)	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7309707B2 (en) *	2002-03-20	2007-12-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
RU2004132222A (ru)	2002-04-04	2005-10-10	Берингер Ингельхайм Фарма Гмбх Унд Ко.Кг (De)	Порошковые композиции, пригодные для ингаляции
UA80123C2 (en)	2002-04-09	2007-08-27	Boehringer Ingelheim Pharma	Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en)	2002-04-09	2003-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Method for the administration of an anticholinergic by inhalation
US7763280B2 (en)	2002-11-28	2010-07-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing powder formulation for inhalation

2001
- 2001-09-28 KR KR10-2002-7007877A patent/KR100488644B1/ko active IP Right Review Request
- 2001-09-28 DK DK01969789T patent/DK1292281T3/da active
- 2001-09-28 AP APAP/P/2003/002774A patent/AP1712A/en active Active
- 2001-09-28 ME MEP-2008-401A patent/ME00245B/me unknown
- 2001-09-28 ES ES01969789T patent/ES2227268T3/es not_active Expired - Lifetime
- 2001-09-28 IL IL14998401A patent/IL149984A0/xx active IP Right Grant
- 2001-09-28 ME MEP-401/08A patent/MEP40108A/xx unknown
- 2001-09-28 OA OA1200300108A patent/OA12522A/fr unknown
- 2001-09-28 CN CNB01803098XA patent/CN1210017C/zh not_active Ceased
- 2001-09-28 EA EA200200551A patent/EA004034B1/ru not_active IP Right Cessation
- 2001-09-28 BR BR0107304-4A patent/BR0107304A/pt active Pending
- 2001-09-28 EP EP04006349A patent/EP1430887A1/de not_active Withdrawn
- 2001-09-28 UA UA2002064932A patent/UA72014C2/uk unknown
- 2001-09-28 DE DE50103551.6T patent/DE50103551C5/de not_active Expired - Lifetime
- 2001-09-28 EP EP01969789A patent/EP1292281B1/de not_active Expired - Lifetime
- 2001-09-28 JP JP2002533832A patent/JP3870159B2/ja not_active Expired - Lifetime
- 2001-09-28 EE EEP200200428A patent/EE04414B1/xx unknown
- 2001-09-28 PT PT01969789T patent/PT1292281E/pt unknown
- 2001-09-28 CA CA002395653A patent/CA2395653C/en not_active Expired - Lifetime
- 2001-09-28 NZ NZ519406A patent/NZ519406A/en not_active IP Right Cessation
- 2001-09-28 SK SK706-2002A patent/SK285389B6/sk not_active IP Right Cessation
- 2001-09-28 DZ DZ013477A patent/DZ3477A1/xx active
- 2001-09-28 AU AU89935/01A patent/AU757008B2/en not_active Expired
- 2001-09-28 AT AT01969789T patent/ATE275391T1/de active
- 2001-09-28 HU HU0203885A patent/HU226982B1/hu unknown
- 2001-09-28 MX MXPA02005666A patent/MXPA02005666A/es active IP Right Grant
- 2001-09-28 SI SI200130160T patent/SI1292281T1/xx unknown
- 2001-09-28 TR TR2004/02367T patent/TR200402367T4/xx unknown
- 2001-09-28 CZ CZ20021785A patent/CZ301465B6/cs not_active IP Right Cessation
- 2001-09-28 WO PCT/EP2001/011227 patent/WO2002030389A1/de active IP Right Grant
- 2001-09-28 PL PL356840A patent/PL200063B1/pl unknown
- 2001-09-28 GE GE5215A patent/GEP20063865B/en unknown
- 2001-09-28 RS YUP-363/02A patent/RS50197B/sr unknown
- 2001-10-09 EG EG20011059A patent/EG24139A/xx active
- 2001-10-09 TW TW090124971A patent/TWI285553B/zh not_active IP Right Cessation
- 2001-10-10 MY MYPI20014706A patent/MY123544A/en unknown
- 2001-10-10 PE PE2001001001A patent/PE20020577A1/es active IP Right Grant
- 2001-10-10 UY UY26959A patent/UY26959A1/es not_active IP Right Cessation
- 2001-10-11 US US09/975,418 patent/US7070800B2/en not_active Expired - Lifetime
- 2001-10-12 AR ARP010104783A patent/AR031819A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 2001-10-15 SA SA01220460A patent/SA01220460B1/ar unknown
2002
- 2002-05-20 HR HR20020437A patent/HRP20020437B1/xx not_active IP Right Cessation
- 2002-05-21 BG BG106730A patent/BG65753B1/bg active Active
- 2002-05-21 ZA ZA200204378A patent/ZA200204378B/xx unknown
- 2002-05-22 NO NO20022414A patent/NO331956B1/no not_active IP Right Cessation
- 2002-05-28 EC EC2002004268A patent/ECSP024268A/es unknown
- 2002-06-03 IL IL149984A patent/IL149984A/en unknown
2003
- 2003-03-26 CR CR6937A patent/CR6937A/es not_active Application Discontinuation
- 2003-04-08 EC EC2003004546A patent/ECSP034546A/es unknown
- 2003-04-08 MA MA27103A patent/MA25843A1/fr unknown
- 2003-04-08 IS IS6771A patent/IS2360B/is unknown
- 2003-04-11 CU CU20030082A patent/CU23284B7/es unknown
- 2003-06-11 HK HK03104094A patent/HK1051812A1/xx not_active IP Right Cessation
- 2003-12-05 US US10/729,543 patent/US20040228806A1/en not_active Abandoned
2005
- 2005-10-20 US US11/254,573 patent/US20060039868A1/en not_active Abandoned
2008
- 2008-07-29 US US12/181,651 patent/US20080292563A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK1292281T3 (da)	2004-10-11
CR6937A (es)	2003-11-28
IS2360B (is)	2008-05-15
EP1292281A1 (de)	2003-03-19
KR100488644B1 (ko)	2005-05-11
EA200200551A1 (ru)	2002-12-26
NO20022414L (no)	2002-05-30
AR031819A1 (es)	2003-10-08
BG106730A (bg)	2003-03-31
PL356840A1 (en)	2004-07-12
US7070800B2 (en)	2006-07-04
HU226982B1 (en)	2010-04-28
DE50103551C5 (de)	2014-08-21
CZ20021785A3 (cs)	2002-09-11
ES2227268T3 (es)	2005-04-01
IL149984A (en)	2007-06-03
EA004034B1 (ru)	2003-12-25
TR200402367T4 (tr)	2004-12-21
OA12522A (en)	2006-05-30
SI1292281T1 (en)	2004-12-31
GEP20063865B (en)	2006-07-10
NO20022414D0 (no)	2002-05-22
ATE275391T1 (de)	2004-09-15
CU23284B7 (es)	2008-06-30
JP2004510805A (ja)	2004-04-08
CA2395653A1 (en)	2002-04-18
HUP0203885A3 (en)	2005-01-28
MY123544A (en)	2006-05-31
US20040228806A1 (en)	2004-11-18
IS6771A (is)	2003-04-08
AU8993501A (en)	2002-04-22
CZ301465B6 (cs)	2010-03-10
ZA200204378B (en)	2003-05-19
ECSP024268A (es)	2002-08-01
CN1392795A (zh)	2003-01-22
RS50197B (sr)	2009-05-06
UA72014C2 (en)	2005-01-17
SA01220460B1 (ar)	2006-10-31
US20020110529A1 (en)	2002-08-15
BG65753B1 (bg)	2009-10-30
MEP40108A (en)	2011-02-10
JP3870159B2 (ja)	2007-01-17
WO2002030389A1 (de)	2002-04-18
ECSP034546A (es)	2003-06-25
HRP20020437B1 (en)	2005-10-31
US20080292563A1 (en)	2008-11-27
EE200200428A (et)	2003-02-17
HK1051812A1 (en)	2003-08-22
TWI285553B (en)	2007-08-21
IL149984A0 (en)	2002-12-01
CA2395653C (en)	2006-05-09
KR20020063912A (ko)	2002-08-05
AU757008B2 (en)	2003-01-30
EG24139A (en)	2008-08-06
US20060039868A1 (en)	2006-02-23
EP1430887A1 (de)	2004-06-23
AP1712A (en)	2007-01-24
HUP0203885A2 (hu)	2003-03-28
NZ519406A (en)	2003-07-25
BR0107304A (pt)	2002-08-13
ME00245B (me)	2011-02-10
EE04414B1 (et)	2005-02-15
CN1210017C (zh)	2005-07-13
EP1292281B1 (de)	2004-09-08
PT1292281E (pt)	2004-11-30
SK285389B6 (sk)	2006-12-07
YU36302A (sh)	2002-09-19
UY26959A1 (es)	2002-06-20
DZ3477A1 (de)	2002-04-18
AP2003002774A0 (en)	2003-03-31
PE20020577A1 (es)	2002-08-08
MXPA02005666A (es)	2002-11-29
PL200063B1 (pl)	2008-12-31
SK7062002A3 (en)	2002-10-08
NO331956B1 (no)	2012-05-14
HRP20020437A2 (en)	2004-08-31
MA25843A1 (fr)	2003-07-01

Legal Events

Date	Code	Title	Description
2005-10-06	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE50103551D1 (de)	2004-10-14	Neue tiotropium-haltige inhalationspulver
ATE460955T1 (de)	2010-04-15	Trockenpulver-inhalator
DE60130156D1 (de)	2007-10-04	Inhalator
ATE271031T1 (de)	2004-07-15	Neue phenylpropargyletherderivate
DE50100715D1 (de)	2003-11-06	Inhalationsvernebler
NO20022922L (no)	2002-08-19	Inhalasjonsanordning
ATE326470T1 (de)	2006-06-15	Neue aza-indolyl derivate
GB0009592D0 (en)	2000-06-07	Respiratory combinations
AU145610S (en)	2001-10-18	Inhaler
NO20022921D0 (no)	2002-06-18	Inhalasjonsanordning
DE60221611D1 (de)	2007-09-20	Trockenpulverinhalator
DE60111268D1 (de)	2005-07-07	Neue pleuromutilinderivate
DE60103033D1 (de)	2004-06-03	Neue phenylheteroalkylamin-derivate
DE60203534D1 (de)	2005-05-04	Neue phenyl-propargylether derivate
DE60123539D1 (de)	2006-11-16	Puderquaste
DE60217710D1 (de)	2007-03-08	Neue formulierung
GB0009617D0 (en)	2000-06-07	Respiratory combinations
AU145556S (en)	2001-10-10	Inhaler
DK1267974T3 (da)	2005-08-01	Inhalationsapparat
FI20011386A0 (fi)	2001-06-28	Inhalaatiopartikkeleja
DE60233952D1 (de)	2009-11-19	Neue serinprotease
SE0000818D0 (sv)	2000-03-10	Iron-based powder
GB0025751D0 (en)	2000-12-06	Inhaler
GB0029979D0 (en)	2001-01-24	Inhaler
AU145135S (en)	2001-09-07	Inhaler